India's pharma market grows 7.8% in April, led by chronic therapies

Chronic therapies and price increases drove 7.8 per cent growth in India's pharma market in April 2025, with cardiac and gastrointestinal segments showing double-digit value gains

The Indian pharmaceutical market (IPM) grew 7.8 per cent in April this year, with almost all major therapies showing positive value growth, according to market research firm Pharmarack. 

 

India Ratings and Research said the continued revenue growth was driven by companies' price hikes, with volume growing 1.3 per cent year-on-year (Y-o-Y). 

 

“India Ratings expects IPM to grow 7-8% Y-o-Y during the financial year 2025-26 (FY26) with sustained growth momentum in the chronic therapies, led by price increases and product launches”, said Nishith Sanghvi, director, corporate ratings, India Ratings. 

 

Therapies such as cardiac and gastrointestinal, accounting for nearly 25 per cent